| Name | Title | Contact Details |
|---|
Paragon Medical is a turnkey supplier of world-class solutions for cases and trays, surgical instrumentation (reusable and single-use), implantable components, and design & development services to the medical device marketplace.
St. Francis Healthcare System of Hawaii offers diverse opportunities to use your skills and experience to serve others and to grow professionally and personally with us
Service and value set Medical Mutual and its Family of Companies apart. A trusted insurer for 80 years, we are the oldest and largest health insurance company headquartered in the state of Ohio. As a mutual company, we operate for the benefit of our members without needing to meet the demands of stockholders or Wall Street analysts. Instead, we focus on developing products and services that allow us to better serve our customers and the communities around us and help our members achieve their best possible health and quality of life. The work you do and the team you choose has a huge impact on your life. If you are seeking a challenging and supportive work environment that will help you be your best, then you belong with an organization that values high performance and ambition — Medical Mutual. Our reputation of great service is the result of an exceptional team effort from our dedicated employees. We offer an attractive compensation package that includes excellent benefits, a 401K plan with a company match, an on-site fitness center, employee wellness programs, professional development and much more. Discover Medical Mutual and all we have to offer.
MedAccuracy is a Lenexa, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic